Canine genomics co. scores $75M in fundingJuly 29, 2021A canine genomics and biotechnology company hoping to increase the lifespan of dogs by three years within the next decade has raised $75 million in Series B funding.
SPONSORED CONTENTActivating their gut microbiomeWith ActivBiome+ ingredient blend, Hill’s Prescription Diet i/d rapidly activates dogs’ gut microbiomes to support digestion. + Learn More